Axial Spondyloarthrithis clinical trials at UC Health
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
Patients receive study drug for one year (Part A). If, after the initial run-in phase, a sustained remission is reached they will be randomly split into one of three dose groups for another year (Part B). The maintenance of the sustained remission will be analyzed.